Niquitin Clear (Nicotine)

Nicotine, the active ingredient in Niquitin Clear, is a nicotinic receptor agonist presented as a transdermal patch for transdermal use. It is employed in smoking cessation therapy for adult smokers, helping to alleviate withdrawal symptoms and reduce cravings associated with nicotine dependence. The patch delivers nicotine steadily through the skin, providing a controlled dose that mimics the nicotine levels of smoking while allowing gradual tapering.

GNH USA supplies Niquitin Clear as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Niquitin Clear, a nicotine transdermal system, is used in smoking cessation therapy to manage nicotine dependence.

- Smoking cessation: helps adult smokers reduce cravings and withdraw from nicotine. - Nicotine dependence: provides controlled nicotine delivery to ease withdrawal symptoms. - Relapse prevention: supports individuals who have quit smoking to maintain abstinence.

Common Side Effects: - Skin irritation at the application site: redness, itching, or mild rash. - Headache: mild to moderate intensity. - Nausea: occasional upset stomach. - Dizziness: transient light‑headedness. - Sleep disturbance: vivid dreams or insomnia. - Mouth irritation: tingling or dryness.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Significant skin rash: widespread erythema or blistering. - Cardiovascular events: hypertension, tachycardia, or chest pain. - Respiratory depression: uncommon but severe breathing difficulty. - Hypotension: sudden drop in blood pressure. - Syncope: fainting episodes.

Before using Niquitin Clear, consider the following precautions: - Cardiovascular assessment: evaluate recent heart disease or hypertension. - Recent myocardial infarction: avoid use within the first few weeks after a heart attack. - Pregnancy and breastfeeding: safety not established; discuss with a healthcare professional. - Concomitant nicotine products: do not use other nicotine replacement therapies simultaneously. - Non‑smokers: the patch is intended only for individuals with nicotine dependence. - Store at room temperature: keep in the original packaging, protect from moisture and direct heat.

Niquitin Clear may interact with other medicines as follows:

Major Interactions (Avoid): - Other nicotine replacement therapies: risk of nicotine overdose. - Monoamine oxidase inhibitors (MAOIs): may increase blood pressure. - Certain antihypertensive agents (e.g., clonidine): nicotine can reduce their effectiveness.

Moderate Interactions (Monitor Closely): - CYP1A2 substrates (e.g., theophylline, clozapine): nicotine may induce metabolism, lowering drug levels. - Antidepressants (e.g., SSRIs): monitor for altered plasma concentrations. - Anticoagulants (e.g., warfarin): nicotine may affect clotting parameters.